UCB and Epilepsy - an ongoing commitment
Posted by
04-Dec-2015
Here at UCB we have a strong track record of supporting epilepsy research. Our scientists and academic partners work tirelessly to improve our understanding of epilepsy and to translate the latest scientific knowledge into improved care for patients.
Scientific conferences are a great opportunity for us to share this important work. UCB has established a tradition of presenting our latest epilepsy research findings to the American Epilepsy Society (AES).
At the 69th AES Annual Meeting, which takes place from 4th to 8th December in Philadelphia, UCB will share 19 presentations on a diverse range of topics.
This contribution to scientific understanding reinforces the important role that research plays in UCB’s ongoing commitment to improving healthcare for people with epilepsy.
These presentations cover our epilepsy medicine as well as a drug currently in development. The research also looks at treatment patterns and outcomes for patients with newly-diagnosed epilepsy; results from a survey of how patients perceive healthcare value; new models for early testing of anti-epileptic therapies; and the role of inflammation in epileptiform activity.
The research exploring inflammation and epilepsy is the subject of a presentation within an Investigator’s Workshop – a session highlighting the most outstanding abstracts on topics related to basic science and clinical research.
This year UCB will have a strong presence on the Exhibit Hall floor at AES. The UCB booth will highlight epilepsy community programmes such as the UCB Family Epilepsy Scholarship Program and UCB support of the Canine Assistants Seizure Response Dogs. UCBCares will also have a presence in the exhibit hall.
Lastly, in an attempt to further our commitment to innovation this year, UCB has helped produce the story of Jane Gauntlett, an adult living with epilepsy, in an immersive experience using the latest virtual reality technology.
Jane will be on hand to guide audiences through her experience for multiple demonstrations offered throughout the day on Saturday and Sunday during exhibit hall hours at the UCB Innovation Pavilion.
Additional activities occurring in the Innovation Pavilion include information on patient programmes and educational resources, and a ‘meet and greet’ with Channing and her dog Georgie from the Canine Assistants Program.
We are pleased to see so much interest in the in-depth work we do to identify and address the unmet needs of patients. UCB’s consistent presence at the annual AES meeting demonstrates a continued commitment to sharing our research findings with the epilepsy healthcare community.
As the programmes showcased in the Exhibit Hall show, we are also supporting a wide range of initiatives designed to improve the lives of people with epilepsy.
Scientific conferences are a great opportunity for us to share this important work. UCB has established a tradition of presenting our latest epilepsy research findings to the American Epilepsy Society (AES).
At the 69th AES Annual Meeting, which takes place from 4th to 8th December in Philadelphia, UCB will share 19 presentations on a diverse range of topics.
This contribution to scientific understanding reinforces the important role that research plays in UCB’s ongoing commitment to improving healthcare for people with epilepsy.
These presentations cover our epilepsy medicine as well as a drug currently in development. The research also looks at treatment patterns and outcomes for patients with newly-diagnosed epilepsy; results from a survey of how patients perceive healthcare value; new models for early testing of anti-epileptic therapies; and the role of inflammation in epileptiform activity.
The research exploring inflammation and epilepsy is the subject of a presentation within an Investigator’s Workshop – a session highlighting the most outstanding abstracts on topics related to basic science and clinical research.
This year UCB will have a strong presence on the Exhibit Hall floor at AES. The UCB booth will highlight epilepsy community programmes such as the UCB Family Epilepsy Scholarship Program and UCB support of the Canine Assistants Seizure Response Dogs. UCBCares will also have a presence in the exhibit hall.
Lastly, in an attempt to further our commitment to innovation this year, UCB has helped produce the story of Jane Gauntlett, an adult living with epilepsy, in an immersive experience using the latest virtual reality technology.
Jane will be on hand to guide audiences through her experience for multiple demonstrations offered throughout the day on Saturday and Sunday during exhibit hall hours at the UCB Innovation Pavilion.
Additional activities occurring in the Innovation Pavilion include information on patient programmes and educational resources, and a ‘meet and greet’ with Channing and her dog Georgie from the Canine Assistants Program.
We are pleased to see so much interest in the in-depth work we do to identify and address the unmet needs of patients. UCB’s consistent presence at the annual AES meeting demonstrates a continued commitment to sharing our research findings with the epilepsy healthcare community.
As the programmes showcased in the Exhibit Hall show, we are also supporting a wide range of initiatives designed to improve the lives of people with epilepsy.
Leave a Comment